## Abstract Parathyroid hormone (PTH) activates multiple signaling pathways following binding to the PTH1 receptor in osteoblasts. Previous work revealed a discrepancy between cAMP stimulation and CRE reporter activation of truncated PTH peptides, suggesting that additional signaling pathways contr
Urinary cyclic AMP response to bovine parathyroid hormone during treatment with neuroleptics
โ Scribed by Derek G. Waller; Janet D. M. Albano; J. Guyedwards
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 206 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
โฆ Synopsis
The urinary cyclic AMP response to bovine parathyroid hormone and urinary concentrating ability (max Uosm) after des-amino-o-arginine vasopressin were studied in nine volunteers and seven patients receiving long-term neuroleptic treatment. Max Uosm was lower in the patient group (770 k 70 mosmol/kg) compared with the controls (948 -t 152 mosmol/kg) but the trend to a lower cAMP response to bovine PTH was not statistically significant. These results suggest that, although adenylate cyclase inhibition may contribute, other mechanisms are also important in the genesis of reduced urine concentrating ability in patients treated with psychotropic drugs.
๐ SIMILAR VOLUMES
In order to clarify the complex interrelationship between serum calcium, 1,25-dihydroxyvitamin D (1,25(OH)2D), and parathyroid hormone (PTH), and the urinary excretion of cyclic AMP (cAMP) in response to exogenous PTH in pseudohypoparathyroidism (PHP) and related diseases, we investigated 3 patients